Peptidic foldamers: ramping up diversity
TA Martinek, F Fülöp - Chemical Society Reviews, 2012 - pubs.rsc.org
Non-natural folded polymers (foldamers) display considerable versatility, and the design of
such molecules is of great current interest. In this respect, peptidic foldamers are perhaps …
such molecules is of great current interest. In this respect, peptidic foldamers are perhaps …
Foldamers as versatile frameworks for the design and evolution of function
CM Goodman, S Choi, S Shandler… - Nature chemical …, 2007 - nature.com
Foldamers are sequence-specific oligomers akin to peptides, proteins and oligonucleotides
that fold into well-defined three-dimensional structures. They offer the chemical biologist a …
that fold into well-defined three-dimensional structures. They offer the chemical biologist a …
β-Peptidic peptidomimetics
D Seebach, J Gardiner - Accounts of chemical research, 2008 - ACS Publications
For more than a decade now, a search for answers to the following two questions has taken
us on a new and exciting journey into the world of β-and γ-peptides: What happens if the …
us on a new and exciting journey into the world of β-and γ-peptides: What happens if the …
Structural chemistry of peptides containing backbone expanded amino acid residues: conformational features of β, γ, and hybrid peptides
PG Vasudev, S Chatterjee, N Shamala… - Chemical …, 2011 - ACS Publications
The remarkable complexity of globular protein structures was first revealed about half a
century ago, when the crystal structure of myoglobin was determined at 2.4 Å. 1 In the …
century ago, when the crystal structure of myoglobin was determined at 2.4 Å. 1 In the …
Helical β-peptide inhibitors of the p53-hDM2 interaction
JA Kritzer, JD Lear, ME Hodsdon… - Journal of the American …, 2004 - ACS Publications
hDM2 is recognized in vivo by a short α-helix within the p53 trans-activation domain
(p53AD). Disruption of the p53⊙ hDM2 interaction is an important goal for cancer therapy. A …
(p53AD). Disruption of the p53⊙ hDM2 interaction is an important goal for cancer therapy. A …
HIV-1 TAR RNA: the target of molecular interactions between the virus and its host
S Bannwarth, A Gatignol - Current HIV research, 2005 - ingentaconnect.com
HIV-1 TAR RNA is the binding site of the viral protein Tat, the trans-activator of the HIV-1
LTR. It is present at the 5'end of all HIV-1 spliced and unspliced mRNAs in the nucleus as …
LTR. It is present at the 5'end of all HIV-1 spliced and unspliced mRNAs in the nucleus as …
β-Peptides as inhibitors of protein–protein interactions
JA Kritzer, OM Stephens, DA Guarracino… - Bioorganic & medicinal …, 2005 - Elsevier
We became interested several years ago in exploring whether 14-helical β-peptide
foldamers could bind protein surfaces and inhibit protein–protein interactions, and if so …
foldamers could bind protein surfaces and inhibit protein–protein interactions, and if so …
α-Aminoxy acids: New possibilities from foldamers to anion receptors and channels
X Li, YD Wu, D Yang - Accounts of chemical research, 2008 - ACS Publications
Naturally occurring peptides serve important functions as enzyme inhibitors, hormones,
neurotransmitters, and immunomodulators in many physiological processes including …
neurotransmitters, and immunomodulators in many physiological processes including …
[HTML][HTML] Small molecule probes of protein aggregation
LM Young, AE Ashcroft, SE Radford - Current opinion in chemical biology, 2017 - Elsevier
Highlights•A range of functionally and structurally unrelated proteins form amyloid.•Toxic
intermediates remain elusive, making their targeting a significant challenge.•Design and …
intermediates remain elusive, making their targeting a significant challenge.•Design and …
Succinct synthesis of β-amino acids via chiral isoxazolines
AA Fuller, B Chen, AR Minter… - Journal of the American …, 2005 - ACS Publications
β-Amino acids are important synthetic targets due to their presence in a wide variety of
natural products, pharmaceutical agents, and mimics of protein structural motifs. While β …
natural products, pharmaceutical agents, and mimics of protein structural motifs. While β …